Image

Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea

Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea

Recruiting
18-65 years
All
Phase N/A

Powered by AI

Overview

This study will be conducted in the coronary intensive care unit of Dr. Siyami Ersek Chest, Heart and Vascular Surgery Training and Research Hospital. It aims to investigate the effect of hand fan therapy on ticagrelor-associated dyspnea in patients receiving ticagrelor.

Description

Patients in the coronary intensive care unit receiving ticagrelor and meeting the inclusion criteria will be included. The study includes two groups: a control group receiving standard care and an experimental group receiving standard care plus hand fan therapy. A total of 110 participants (55 per group) will be recruited. Randomization will be performed using a computer-based randomization program. Due to the nature of the intervention and sample characteristics, participants and the researcher will not be blinded. Data will be analyzed by a statistician not involved in the study, and the findings will be reported.

Eligibility

Inclusion Criteria:

  • Between the ages of 18 and 65,
  • No severe hearing and vision problems,
  • Can speak and understand Turkish,
  • Easy to communicate with,
  • First-time sufferer of acute coronary syndrome (ACS) for the first time,
  • Decided to start ticagrelor therapy,
  • Able to adapt to treatment,
  • Individuals who volunteered to participate in the research.

Exclusion Criteria:

  • Having any problem that prevents you from communicating cognitively, emotionally and verbally,
  • Obstructive sleep abnormalities,
  • Have a disease that affects respiratory function (stage IV cancer, bronchial asthma, COVID-19, lung cancer, pulmonary edema, chronic obstructive pulmonary disease, pulmonary hypertension, pulmonary embolism, pneumonia or bronchitis, etc.),
  • With metabolic abnormalities,
  • Intubated after the procedure,
  • Previously treated with ticagrelor,
  • Individuals who did not volunteer to participate in the study. Losses to follow up
  • Individuals who wish to leave the study voluntarily.
  • Saturation value below 95%,
  • The one with the arrest,
  • Who will not be able to fulfill the requirements of the work,
  • Individuals with life-threatening conditions

Study details
    Acute Coronary Syndromes
    Ticagrelor
    Dyspnea

NCT07268859

Acibadem University

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.